{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:56:28Z","timestamp":1781182588819,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132314-B-705\\u2013001"],"award-info":[{"award-number":["NSTC 112\\u20132314-B-705\\u2013001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012537","name":"Chiayi Christian Hospital","doi-asserted-by":"publisher","award":["R109\\u201339\\u20132"],"award-info":[{"award-number":["R109\\u201339\\u20132"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012537","name":"Chiayi Christian Hospital","doi-asserted-by":"publisher","award":["U111\\u201301"],"award-info":[{"award-number":["U111\\u201301"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tranon.2025.102599","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:08:17Z","timestamp":1767683297000},"page":"102599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor derived adiponectin induces immunosuppressive macrophages in upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"64","author":[{"given":"Cheng-Huang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PiChe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Bin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien-Ping","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Yan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-185X","authenticated-orcid":false,"given":"Shu-Fen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.tranon.2025.102599_bib0001","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jfma.2023.06.003","article-title":"Impact of pathological response on oncological outcomes in patients with upper tract urothelial cancer receiving neo-adjuvant chemotherapy","volume":"122","author":"Yu","year":"2023","journal-title":"J. Formos Med. Assoc."},{"issue":"10232","key":"10.1016\/j.tranon.2025.102599_bib0002","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.tranon.2025.102599_bib0003","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1002\/cam4.6084","article-title":"Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: a birth cohort study","volume":"12","author":"Chang","year":"2023","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.tranon.2025.102599_bib0004","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/iju.15278","article-title":"Recent advances in immune checkpoint inhibitors in the treatment of urothelial carcinoma: a review","volume":"30","author":"Kato","year":"2023","journal-title":"Int. J. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102599_bib0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/bco2.335","article-title":"Immune checkpoint inhibitors in high-grade upper tract urothelial carcinoma: paradigm shift emphasizing organ preservation","volume":"5","author":"Khalil","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.tranon.2025.102599_bib0006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/CMAR.S445529","article-title":"Upper tract urothelial carcinoma (UTUC): prevalence, Impact and management challenge","volume":"16","author":"Nally","year":"2024","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2025.102599_bib0008","article-title":"Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0009","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tranon.2025.102599_bib0010","doi-asserted-by":"crossref","unstructured":"U. International Journal of CancerAmmarah, A. Pereira-Nunes, M. Delfini, M. Mazzone, From monocyte-derived macrophages to resident macrophages-how metabolism leads their way in cancer, Mol. Oncol. 18 (7) (2024) 1739\u20131758.","DOI":"10.1002\/1878-0261.13618"},{"key":"10.1016\/j.tranon.2025.102599_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871513","article-title":"Targeting the tumor microenvironment: a close up of tumor-associated macrophages and neutrophils","volume":"12","author":"Russo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2025.102599_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2025.102599_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105880","article-title":"A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting","volume":"76","author":"Sharifi","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0014","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41416-022-02049-1","article-title":"The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)","volume":"128","author":"Xu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2025.102599_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102599_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2025.102599_bib0017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2025.102599_bib0018","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102599_bib0019","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/cimb46030139","article-title":"Increased apolipoprotein A1 expression correlates with tumor-associated neutrophils and t lymphocytes in upper tract urothelial carcinoma","volume":"46","author":"Chang","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells14090660","article-title":"Immunosuppression of tumor-derived factors modulated neutrophils in upper tract urothelial carcinoma through upregulation of arginase-1 via ApoA1-STAT3 Axis","volume":"14","author":"Chang","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00281-023-00988-2","article-title":"The role of macrophages in the tumor microenvironment and tumor metabolism","volume":"45","author":"Sadhukhan","year":"2023","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102599_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12964-023-01424-6","article-title":"Macrophage barrier in the tumor microenvironment and potential clinical applications","volume":"22","author":"Ji","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.tranon.2025.102599_bib0023","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","article-title":"Monocyte regulation in homeostasis and malignancy","volume":"42","author":"Robinson","year":"2021","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102599_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93414-2","article-title":"Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment","volume":"11","author":"Goto","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102599_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","article-title":"Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: a key player in tumor immunotherapy","volume":"67","author":"Li","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0027","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2004.08.145","article-title":"Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes","volume":"323","author":"Wolf","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0028","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","author":"Ohashi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.tranon.2025.102599_bib0029","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ijc.29485","article-title":"Modulatory effects of adiponectin on the polarization of tumor-associated macrophages","volume":"137","author":"Peng","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2025.102599_bib0030","article-title":"Adiponectin deficiency enhances anti-tumor immunity of CD8(+) T cells in rhabdomyosarcoma through inhibiting STAT3 activation","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102599_bib0031","first-page":"3033","article-title":"The role of adipocytokines and their receptors in bladder cancer: expression of adiponectin or leptin is an independent prognosticator","volume":"12","author":"Kashiwagi","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0032","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11154-013-9283-3","article-title":"Adiponectin and energy homeostasis","volume":"15","author":"Lee","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0033","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/dom.15151","article-title":"The role of adiponectin for immune cell function in metabolic diseases","volume":"25","author":"Gao","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tranon.2025.102599_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1244586","article-title":"Regulation of lung inflammation by adiponectin","volume":"14","author":"Lim","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102599_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041219","article-title":"Multifaceted physiological roles of adiponectin in inflammation and diseases","volume":"21","author":"Choi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2025.102599_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010097","article-title":"The role of adipokines in tumor progression and its association with obesity","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.tranon.2025.102599_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.685923","article-title":"Targeting adipokines in obesity-related tumors","volume":"11","author":"Pu","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102599_bib0038","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/ijc.25861","article-title":"Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients","volume":"129","author":"Arano","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2025.102599_bib0039","doi-asserted-by":"crossref","first-page":"106","DOI":"10.32725\/jab.2022.012","article-title":"Genetic variation in the ADIPOQ gene and serum adiponectin increase the risk of bladder cancer","volume":"20","author":"Elsalem","year":"2022","journal-title":"J. Appl. Biomed."},{"issue":"12","key":"10.1016\/j.tranon.2025.102599_bib0040","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1161\/STROKEAHA.119.026280","article-title":"Intensive statin therapy compromises the adiponectin-adipor pathway in the human monocyte-macrophage lineage","volume":"50","author":"Gasbarrino","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.tranon.2025.102599_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.718929","article-title":"Adiponectin inhibits the production of TNF-alpha, IL-6 and chemokines by human lung macrophages","volume":"12","author":"Salvator","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102599_bib0042","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jmcb\/mjw012","article-title":"Adiponectin: a versatile player of innate immunity","volume":"8","author":"Luo","year":"2016","journal-title":"J. Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102599_bib0043","doi-asserted-by":"crossref","first-page":"H656","DOI":"10.1152\/ajpheart.00115.2010","article-title":"Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages","volume":"299","author":"Lovren","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102599_bib0044","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1084\/jem.20181288","article-title":"Adiponectin accounts for gender differences in hepatocellular carcinoma incidence","volume":"216","author":"Manieri","year":"2019","journal-title":"J. Exp. Med."},{"issue":"10031","key":"10.1016\/j.tranon.2025.102599_bib0045","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tranon.2025.102599_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1215","article-title":"Significance of PD-L1 in metastatic urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"7","author":"Maiorano","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tranon.2025.102599_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:57:55Z","timestamp":1781179075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S1936523325003304"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102599","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor derived adiponectin induces immunosuppressive macrophages in upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102599"}}